The company's exclusive research and production of drugs: new anti-tumor drugs "National Medicine Zhunzi B200500 15" and "Poria Polysaccharide Oral Liquid" were listed in 2006 and won the national invention patent and the second prize of the second national patent technology "invention". The exclusive cardiovascular and cerebrovascular drug "Compound Ginkgo Tongmai Oral Liquid" was officially listed in 2008. The extract of tripterygium wilfordii hook., an anti-rheumatic drug, provides a good source of raw materials for manufacturers of various rheumatic and rheumatoid drugs. OTC products such as Ejiao Yishou Oral Liquid, Yiqi Yangxue Oral Liquid and Jianer Xiaoshi Oral Liquid were also launched in 2008.
Based on pachyman, the company has developed a series of nutritional and health foods such as Butian capsule, Poria sclerotiorum soft capsule, Butian liquid, calcium, iron, zinc, selenium oral liquid, compound amino acid oral liquid and Ganoderma lucidum oral liquid.
Carboxymethyl poria cocos polysaccharide intravenous injection, a new kind of anti-tumor drug developed and produced exclusively, will be listed soon, and this project has been included in the national major scientific and technological project of "New Drug Creation" in the Eleventh Five-Year Plan.